BlossomHill Therapeutics, Inc.
 
 
 
 
公司概覽
業務類別 Biotechnology
業務概覽 BlossomHill Therapeutics Inc is a clinical-stage biopharmaceutical company applying its intentional, chemistry-based approach to develop small molecule medicines that address unmet medical needs in cancer treatment. Its product pipeline includes two clinical-stage programs: BH-30643, an investigational, non-covalent, macrocyclic, brain active, mutant-selective OMNI-EGFR inhibitor for the treatment of epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer (NSCLC), and BH-30236, an investigational macrocyclic CDC-like kinase (CLK) inhibitor being evaluated first in relapsed or refractory acute myeloid leukemia (R/R AML) and higher-risk myelodysplastic syndromes (HR-MDS), and the preclinical-stage product candidate BH-501284 targeting activated KRAS.
公司地址 10255 Science Center Drive, Suite 200, San Diego, CA, USA, 92121
電話號碼 +1 858 732-3880
傳真號碼 --
公司網頁 https://www.bhtherapeutics.com
員工數量 63
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Dr. J. Jean Cui President, Chief Executive Officer, Director -- 17/07/2026
Mr. Jason Keyes Chief Financial Officer and Executive Vice President -- 17/07/2026
Mr. Vincent Liptak General Counsel and Executive Vice President -- 17/07/2026
Dr. Geoff Oxnard Chief Medical Officer and Executive Vice President -- 17/07/2026
 
董事會成員
董事會 職務 更新日期
Dr. Carl L. Gordon, C.F.A.,PhD Director 17/07/2026
Dr. Sheila Gujrathi, M.D. Director 17/07/2026
Ms. Bihua Chen, M.B.A. Director 17/07/2026
Dr. Sundeep Agrawal, M.D. Director 17/07/2026
Mr. John Schmid Director 17/07/2026
Dr. J. Jean Cui President, Chief Executive Officer, Director 17/07/2026
Dr. Y. Peter Li, PhD Chairman of the Board 17/07/2026
Dr. Timothy Stubbs, M.D. Director 17/07/2026
 
所屬ETF (更新日期: 17/10/2026 04:22)
代號 名稱 佔比% ▼ 持有日期
VTWOVanguard Russell 2000 ETF0.03%30/09/2026
VTWGVanguard Russell 2000 Growth ETF0.003%30/09/2026
VTWVVanguard Russell 2000 Value ETF0.001%30/09/2026
VTHRVanguard Russell 3000 ETF0.0004%30/09/2026
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.